Another reminder that it's never too late to get a flu shot GRAND RAPIDS, Mich. , Jan. 9, 2017 /PRNewswire/ -- Meijer stores have experienced a 30 percent increase in cold and flu remedies being purchased over the counter at its pharmacies ...
- 2016 Total revenues are expected to be approximately $146 million WASHINGTON , Jan. 9, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization ...
- M&A value exceeded US$200b in 2016 ...
Event Panels to Discuss Value of Real-World Evidence (RWE) and Digital Medicine BURLINGTON, Mass. , Jan. 8, 2017 /PRNewswire/ -- inVentiv Health, a global professional services organization designed to help the biopharmaceutical industry ...
(“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory ...
BOCA RATON, Fla. , Jan. 6, 2017 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced that FDA has granted final approval of its ANDA bendamustine hydrochloride powder for IV (infusion), 25 mg/vial and 100 mg/vial, a generic version ...
REDWOOD CITY, Calif. , Jan. 6, 2017 /PRNewswire/ -- Guardant Health today announced that it has entered into separate agreements with AstraZeneca, Merck (known as MSD outside the United States and Canada ), Merck KGaA, Darmstadt, Germany ...
HAYWARD, Calif. , Jan. 6, 2017 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) containing a ...
SOUTH PLAINFIELD, N.J. , Jan. 6, 2017 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to RG7916 for the treatment of patients ...
BOSTON , Jan. 6, 2017 /PRNewswire/ -- ORIG3N Inc., a Boston -based biomedical research company, announced today that its CEO, Robin Y. Smith , will present a company overview at the 9th Annual Biotech Showcase . The presentation will take ...
Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...
The efficacy of mRNA vaccine technology demonstrated during the COVID-19 pandemic provides optimism for its utilization in mitigating preventable illnesses across various disease domains ( ). ...
An intradermal monkeypox (Mpox) vaccination regimen with reduced dosage proved safe and elicited an antibody response comparable to the standard regimen at six weeks (two weeks post-second dose). ...
The World Health Organization (WHO) granted prequalification to a novel oral cholera vaccine on April 12. The Euvichol-S oral vaccine, which is inactivated, demonstrates comparable effectiveness to the current vaccines, ...
Alectinib, a molecule developed by Genentech, Inc has been granted approval by the Food and Drug Administration on April 18, 2024, for the adjuvant treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers